The Board of Directors of Zydus Lifesciences is set to consider a proposal to raise up to ₹5,000 crore at an upcoming meeting on November 6, 2025. The funds may be raised through various means, including qualified institutions placement, rights issue, preferential allotment, or a combination thereof. The company will also seek shareholder approval for the proposal.
Fundraising Proposal
Zydus Lifesciences is considering raising funds up to ₹5,000 Crores. The decision is scheduled for discussion at the Board meeting on November 6, 2025. The fundraise is intended to strengthen the company’s financial position and support future growth initiatives.
Methods of Fundraising
The company is evaluating multiple options for raising the capital. These include:
- Qualified institutions placement(s)
- Rights issue
- Preferential allotment
- Private placement(s)
- Any combination of these methods
The final method will be determined based on market conditions and regulatory approvals. All options are subject to the approval of the members of the Company.
Shareholder Approval
Zydus Lifesciences will convene a postal ballot process to seek approval of the shareholders of the Company in respect of the aforementioned fundraising proposal.
Trading Window Closure
In accordance with the company’s Code of Fair Disclosure and Conduct, the trading window for dealing in the securities of the Company has been closed for designated persons and their immediate relatives until 48 hours after the conclusion of the Board meeting.
Source: BSE
